- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07104474
- Original Trial
Adaptation and Evaluation of RESTORE
REducing Nurse Burnout Through SysTems Analysis and Organizational REdesign (RESTORE)
The purpose of this clinical trial is to test whether the RESTORE intervention works to reduce nurse burnout, by engaging nursing staff in system redesign to reduce job demands and increase job resources.
Participants in the RESTORE intervention process will be interviewed about:
- their experience with RESTORE
- their experiences working on a unit where RESTORE was used
Participants will also complete surveys of the impact of RESTORE on job demands, job resources, burnout, and work engagement.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- University of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Aim 1 and Aim 2:
Inclusion Criteria:
- Nursing staff employed on one of the study units and involved in direct patient care
Exclusion Criteria:
- Nursing staff that are not involved in direct patient care, travel and float nursing staff
Aim 3:
Inclusion Criteria:
- Hospital and system leaders from one of the following groups
- leaders from hospitals that participated in Aims 1 and 2, OR
- other leaders from our partner health systems, OR
- leaders from other hospital settings
- leaders from hospital advocacy or quality organizations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Post-RESTORE Implementation
All staff working on the unit will be exposed to the outcomes of the RESTORE intervention and will be included in survey and interview data collection post-implementation.
|
RESTORE is a process intervention that combines systems analysis and human-centered design (HCD) approaches to directly engage hospital nursing staff in ongoing organizational redesign to address burnout.
Specifically, RESTORE is comprised of multiple in-person sessions with hospital unit design teams.
In these sessions, hospital nurses are guided through using a well-known systems analysis model to understand their unit, including what factors act as drivers of burnout, what can be modified, and/or what constraints might be in place regarding system changes.
Then, using HCD, nursing staff design, develop, and implement a system redesign solution to address the unique drivers of burnout in their unit that works within their constraints.
|
|
No Intervention: Baseline Pre-Intervention
Data will be collected from nursing staff before RESTORE is implemented on each unit.
|
|
|
Experimental: RESTORE Design Team
Nursing staff will be identified from each unit to participate on the unit system design team.
These staff will be directly exposed to the RESTORE intervention through participation in RESTORE sessions.
These staff will participate in interviews about their experiences with the RESTORE intervention.
|
RESTORE is a process intervention that combines systems analysis and human-centered design (HCD) approaches to directly engage hospital nursing staff in ongoing organizational redesign to address burnout.
Specifically, RESTORE is comprised of multiple in-person sessions with hospital unit design teams.
In these sessions, hospital nurses are guided through using a well-known systems analysis model to understand their unit, including what factors act as drivers of burnout, what can be modified, and/or what constraints might be in place regarding system changes.
Then, using HCD, nursing staff design, develop, and implement a system redesign solution to address the unique drivers of burnout in their unit that works within their constraints.
|
|
No Intervention: Aim 3 Interview Participants
Participants from four groups (listed below) will participate in interviews to identify ongoing barriers and facilitators that impact scalability of RESTORE.
These four groups include: 1) leaders from hospitals that participated in the trial of RESTORE, 2) other leaders from our partner health systems, 3) leaders from other hospitals, and 4) leaders from advocacy or quality organizations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Maslach Burnout Inventory (MBI)
Time Frame: Baseline to 30 months (measured quarterly)
|
MBI is comprised of 22 items and will be used to assess three dimensions of burnout: Emotional Exhaustion, Depersonalization, and Personal Accomplishment.
It is scored on a 7-point Likert scale, where 0 = Never and 6 = Every day.
Scores range from 0 to 132 with higher scores indicating greater levels of burnout.
|
Baseline to 30 months (measured quarterly)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Areas of Worklife Scale (AWS)
Time Frame: Baseline to 30 months (measured quarterly)
|
AWS measures six areas of worklife that characterize the job demands and resources in the organizational context of burnout: Workload, Control, Reward, Community, Fairness, and Values.
The AWS is comprised of 28 items and a separate score is calculated for each of the six areas of worklife.
Scores are reported on a 5-point Likert scale, where 1 = Strongly Disagree and 5 = Strongly Agree.
Aggregate score across the areas will be reported rather than 6 different scores.
Aggregate score ranges from 28-140 with higher scores indicating a better match between the individual and their work environment, and lower scores indicating a mismatch.
|
Baseline to 30 months (measured quarterly)
|
|
Change in Utrecht Work Engagement Scale (UWES)
Time Frame: Baseline to 30 months (measured quarterly)
|
UWES measures nursing staff work engagement.
It is a 9-item survey scored on a 7-point Likert scale.
0 = Never and 6 = Always / Every day.
Range of scores is from 0 - 54, with lower scores indicating less engagement.
|
Baseline to 30 months (measured quarterly)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
RESTORE Process Design Team Debrief Interviews
Time Frame: Up to 3 months
|
Qualitative analysis will be used to identify themes in the experiences of members of the RESTORE unit design teams.
Study team members led by one of the MPIs will analyze the data and use a content analysis approach to identify themes that are emergent from the data
|
Up to 3 months
|
|
Post-implementation Qualitative Interviews
Time Frame: Up to 3 months
|
Qualitative analysis will be used to identify themes in the experiences of nursing staff working on the study units after RESTORE is implemented.
Study team members led by one of the MPIs will analyze the data and use a content analysis approach to identify themes that are emergent from the data
|
Up to 3 months
|
|
Aim 3 Qualitative Interviews - Barriers and Facilitators to Scalability and Dissemination of RESTORE
Time Frame: Up to 3 months
|
The study team will conduct interviews with 4-5 leaders from four groups (n=16-20 total participants): 1) leaders from hospitals that participated in the clinical trial, 2) other leaders from participating health systems, 3) leaders from other hospitals, and 4) leaders from advocacy or quality organizations.
Interviews will focus on identifying the needs and potential barriers or facilitators to implementation of RESTORE in new settings, required adaptations to fit RESTORE to local settings and priorities, and required elements of the RESTORE implementation package.
Interview transcripts will be analyzed using directed content analysis to identify themes.
|
Up to 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Linsey Steege, PhD, University of Wisconsin, Madison
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-0039
- A545000 (Other Identifier: UW Madison)
- NUR/FACULTY AFFAIRS/ADMIN (Other Identifier: UW Madison)
- 1R01NR021386-01 (U.S. NIH Grant/Contract)
- Protocol Version 1/14/25 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nurse
-
Heyam Adnan JabbarNot yet recruitingNurse Scope, Practice | Nurse Training | Nurse Based Care Management | Nurse Led InterventionsIraq
-
University of MichiganEnrolling by invitationNurse-Patient Relations | Nurse RoleUnited States
-
University of BeykentNot yet recruiting
-
Merve BEKEThe Scientific and Technological Research Council of TurkeyCompleted
-
Chinese University of Hong KongCompleted
-
Istanbul University - CerrahpasaCompleted
-
Karadeniz Technical UniversityActive, not recruiting
-
Peking University Third HospitalUnknown
-
Zeynep Kandemir özsoyGazi UniversityRecruitingNurse EducationTurkey (Türkiye)
Clinical Trials on RESTORE
-
Massachusetts General HospitalNational Cancer Institute (NCI)RecruitingTriple Negative Breast Cancer (TNBC)United States
-
Gabriella C. van ZantenCompletedProbiotics | Elderly | Gut Microbiota | Clostridium Difficile | Fecal MetabolomeDenmark
-
Defense and Veterans Center for Integrative Pain...Completed
-
Massachusetts General HospitalAmerican Society for Dermatologic SurgeryCompleted
-
University of Dublin, Trinity CollegeSt Vincent's University Hospital, Ireland; Health Research Board, Ireland; St... and other collaboratorsRecruitingGastric Cancer | Pancreatic Cancer | Liver Cancer | Oesophageal CancerIreland
-
University of Colorado, DenverEnrolling by invitationMeibomian Gland DysfunctionUnited States
-
Universitaire Ziekenhuizen KU LeuvenMedtronicCompletedDepression | Obsessive-compulsive Disorder
-
University of MinnesotaNational Cancer Institute (NCI)CompletedProstatic NeoplasmUnited States
-
ReWalk Robotics, Inc.Spaulding Rehabilitation Hospital; Kessler Foundation; TIRR Memorial Hermann; Shirley... and other collaboratorsUnknownStroke | Hemiplegia | Stroke, Acute | Stroke Hemorrhagic | Hemiparesis | Cerebrovascular AccidentUnited States
-
C. R. BardCompletedObesityUnited States